| Literature DB >> 23481676 |
Chi-Jen Tai1, Jui-Hsin Su, Chiung-Yao Huang, Ming-Shyan Huang, Zhi-Hong Wen, Chang-Feng Dai, Jyh-Horng Sheu.
Abstract
Five new eunicellin-basedEntities:
Mesh:
Substances:
Year: 2013 PMID: 23481676 PMCID: PMC3705370 DOI: 10.3390/md11030788
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Chart 1Structures of metabolites 1–12.
13C NMR Data for Compounds 1–5.
| C | 1 a | 2 a | 3 b | 4 b | 5 a |
|---|---|---|---|---|---|
| 1 | 43.3, CH c | 45.8, CH | 44.7, CH | 44.9, CH | 46.6, CH |
| 2 | 91.4, CH | 90.6, CH | 90.9, CH | 90.8, CH | 92.6, CH |
| 3 | 84.4, C | 84.7, C | 84.2, C | 84.6, C | 85.6, C |
| 4 | 28.4, CH2 | 33.2, CH2 | 33.2, CH2 | 32.6, CH2 | 35.8, CH2 |
| 5 | 35.3, CH2 | 30.2, CH2 | 29.7, CH2 | 38.3, CH2 | 28.5, CH2 |
| 6 | 66.9, CH | 214.8, C | 217.0, C | 213.4, C | 82.3, CH |
| 7 | 152.2, C | 48.3, CH | 40.7, CH | 40.6, CH | 78.0, C |
| 8 | 77.3, CH | 42.4, CH2 | 78.5, CH | 37.7, CH2 | 78.5, CH |
| 9 | 83.7, CH | 81.9, CH | 85.5, CH | 78.9, CH | 78.3, CH |
| 10 | 47.9, CH | 52.1, CH | 47.5, CH | 49.4, CH | 52.0, CH |
| 11 | 145.2, C | 142.1, C | 141.0, C | 141.6, C | 148.5, C |
| 12 | 31.3, CH2 | 73.1, CH | 72.8, CH | 73.0, CH | 31.6, CH2 |
| 13 | 25.7, CH2 | 28.5, CH2 | 28.9, CH2 | 28.7, CH2 | 25.5, CH2 |
| 14 | 39.1, CH | 35.3, CH | 35.6, CH | 35.7, CH | 44.0, CH |
| 15 | 22.2, CH3 | 22.3, CH3 | 22.6, CH3 | 22.6, CH3 | 22.8, CH3 |
| 16 | 118.1, CH2 | 17.8, CH3 | 14.1, CH3 | 15.4, CH3 | 18.5, CH3 |
| 17 | 112.0, CH2 | 118.1, CH2 | 119.5, CH2 | 118.7, CH2 | 109.2, CH2 |
| 18 | 32.6, CH | 28.0, CH | 27.2, CH | 27.5, CH | 29.0, CH |
| 19 | 67.5, CH2 | 21.5, CH3 | 21.6, CH3 | 21.5, CH3 | 21.9, CH3 |
| 20 | 10.6, CH3 | 16.6, CH3 | 14.9, CH3 | 14.9, CH3 | 15.4, CH3 |
| 3- | 172.5, C | 172.5, C | 173.1, C | ||
| 37.4, CH2 | 37.3, CH2 | 36.5, CH2 | |||
| 18.5, CH2 | 18.4, CH2 | 18.4, CH2 | |||
| 13.6, CH3 | 13.7, CH3 | 13.8, CH3 | |||
| 3-OAc | 169.6, C | 169.7, C | |||
| 22.4, CH3 | 22.3, CH3 | ||||
| 6-OAc | 171.6, C | ||||
| 21.4, CH3 | |||||
| 8- | 173.3, C | ||||
| 36.7, CH2 | |||||
| 18.2, CH2 | |||||
| 13.5, CH3 | |||||
| 12-OAc | 170.2, C | 170.1, C | 170.2, C | ||
| 21.6, CH3 | 21.5, CH3 | 21.4, CH3 | |||
| 19-OAc | 171.2, C | ||||
| 21.0, CH3 |
a Spectra recorded at 100 MHz in CDCl3. b Spectra recorded at 125 MHz in CDCl3. c Deduced from DEPT.
1H NMR Data for Compounds 1–5.
| H | 1 a | 2 a | 3 b | 4 b | 5 a |
|---|---|---|---|---|---|
| 1 | 2.25 m | 2.25 dd | 2.28 m | 2.29 m | 2.17 m |
| (12.4, 7.2) | |||||
| 2 | 3.71 br s | 3.67 br s | 3.81 br s | 3.73 br s | 3.63 br s |
| 4 | 1.64 m | 2.03 m | 2.23 m | 2.19 m | 1.96 m |
| 5 | 1.74 m | 1.91 m | 1.25 m | 2.25 m | 1.56 m |
| 6 | 4.73 dd | 5.71 d (5.6) | |||
| (11.2, 4.0) c | |||||
| 7 | 2.58 m | 2.32 m | 2.68 m | ||
| 8 | 4.18 d (3.2) | 1.88 m | 3.77 d (8.5) | 1.87 t (5.0) | 5.27 d (9.2) |
| 2.00 m | 2.24 m | ||||
| 9 | 4.19 d (6.8) | 4.12 ddd | 4.43 d (11.0) | 4.23 dt | 4.11 t (8.8) |
| (11.6, 8.8, 4.4) | (10.0, 5.0) | ||||
| 10 | 2.87 dd | 3.12 t (7.6) | 2.91 t (7.5) | 3.07 td | 3.39 t (7.2) |
| (10.8, 8.0) | (10.0, 1.5) | ||||
| 12 | 2.10 m | 5.49 t (2.8) | 5.52 br s | 5.49 t (2.5) | 2.03 m |
| 2.27 m | 2.23 m | ||||
| 13 | 1.11 m | 1.26 m | 1.32 m | 1.29 m | 1.08 m |
| 14 | 1.55 m | 1.71 m | 1.76 m | 1.71 m | 1.23 m |
| 15 | 1.63 s | 1.40 s | 1.49 s | 1.48 s | 1.38 s |
| 16 | 5.22 s | 1.06 d (7.2) | 1.26 d (6.5) | 1.07 d (7.0) | 1.08 s |
| 5.51 s | |||||
| 17 | 4.65 s | 4.99 d (1.6) | 4.96 s | 4.97 s | 4.51 s |
| 4.81 s | 5.91 d (1.6) | 5.27 s | 5.28 s | 4.64 s | |
| 18 | 2.08 m | 1.76 m | 1.84 m | 1.81 m | 1.69 m |
| 19 | 3.94 t (6.4) | 0.91 d (6.8) | 0.96 d (7.0) | 0.93 d (6.5) | 0.96 d (6.8) |
| 20 | 0.80 s | 0.75 d (6.8) | 0.78 d (7.0) | 0.77 d (6.5) | 0.77 d (6.8) |
| 3- | 2.10 m | 2.28 m | 2.25 m | ||
| 1.57 m | 1.68 m | 1.68 m | |||
| 0.92 t (7.2) | 0.99 t (7.5) | 0.98 t (7.6) | |||
| 3-OAc | 2.18 s | 2.14 s | |||
| 6-OAc | 2.09 s | ||||
| 8- | 2.55 m | ||||
| 1.61 m | |||||
| 0.96 t (7.2) | |||||
| 12-OAc | 2.00 s | 2.03 s | 1.98 s | ||
| 19-OAc | 2.07 s |
a Spectra recorded at 400 MHz in CDCl3. b Spectra recorded at 500 MHz in CDCl3. c J values (Hz) in parentheses.
Figure 1Selected 1H–1H COSY (▬) and HMBC (→) correlations of 1, 2 and 5.
Figure 2Key NOESY correlations for 1 and 2.
Figure 3Key NOESY correlations for 5.
Cytotoxicity (ED50 μg/mL) of compounds 5, 6, 10 and 12.
| Cell Lines | Normal Cell Line | |||||
|---|---|---|---|---|---|---|
| Compounds | A549 | BT483 | H1299 | HepG2 | SAS | BEAS2B |
| 15.0 ± 3.5 | 11.5 ± 1.8 | 19.2 ± 4.0 | 12.9 ± 3.1 | 10.2 ± 3.5 | – a | |
| 16.1 ± 1.2 | 10.0 ± 1.8 | 11.8 ± 1.0 | – a | 17.2 ± 0.4 | 10.4 ± 0.3 | |
| 6.8 ± 1.0 | 11.6 ± 2.8 | 6.7 ± 0.7 | 8.5 ± 1.3 | 9.5 ± 3.7 | 4.8 ± 0.7 | |
| 12.2 ± 1.1 | 6.8 ± 0.6 | 12.8 ± 1.2 | 11.1 ± 0.4 | 10.3 ± 0.5 | 13.6 ± 0.5 | |
| Taxol | 1.5 ± 0.9 | 3.9 ± 0.8 | 1.2 ± 0.1 | 1.4 ± 0.7 | 2.3 ± 1.5 | 2.3 ± 1.5 |
a IC50 > 20 μg/mL.
Figure 4Effect of compounds 1–12 on LPS-induced iNOS and COX-2 proteins expression in RAW264.7 macrophage cells by immunoblot analysis. The values are mean ± SEM. (n = 6). Relative intensity of the LPS alone stimulated group was taken as 100%.* Significantly different from LPS alone stimulated group (* P < 0.05). a stimulated with LPS, b stimulated with LPS in the presence of 1–12 (10 μM).